Overview

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Primary Objective: - Response rate (by contrast CT scan) Secondary Objectives: - Progression-free survival (PFS) - Overall survival (OS)
Phase:
Phase 2
Details
Lead Sponsor:
Sanofi
Treatments:
Carboplatin
Cisplatin
Docetaxel